AARON KENT: Open Payments
NPI 1497343529 · PORT ST LUCIE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,496 in 134 payments from 22 companies in 2025. Trend: 2023 $1,151 · 2024 $2,933 · 2025 $6,496
Food & beverage: $3,593Consulting: $2,760Travel & lodging: $135Education: $8
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $1,918 |
| UCB, Inc. | 14 | $1,865 |
| Janssen Biotech, Inc. | 14 | $477 |
| ABBVIE INC. | 24 | $451 |
| Galderma Laboratories, L.P. | 8 | $339 |
| Regeneron Healthcare Solutions, Inc. | 11 | $302 |
| Amgen Inc. | 13 | $204 |
| GENZYME CORPORATION | 8 | $176 |
| Lilly USA, LLC | 4 | $100 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $88 |
Products named: COSENTYX, Bimzelx, TREMFYA, DUPIXENT, NEMLUVIO, SKYRIZI, OTEZLA, RINVOQ.
Industry payments across FL — which companies pay providers there.
